Home / Inspections / 1205037

FDA Inspection 1205037 — BioLyte Laboratories, LLC

BioLyte Laboratories, LLC — FEI 3013171766

The FDA completed an inspection of BioLyte Laboratories, LLC on April 27, 2023 in Grand Rapids, MI. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
April 27, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Grand Rapids, MI (United States)

Facility

Other inspections at this facility

  • 1287796 (OAI Fri Sep 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1203096 (NAI Thu Apr 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1113105 (OAI Wed Dec 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1035012 (VAI Fri Dec 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources